[Federal Register Volume 65, Number 46 (Wednesday, March 8, 2000)] [Corrections] [Page 12318] From the Federal Register Online via the Government Publishing Office [www.gpo.gov] [FR Doc No: C0-4009] ----------------------------------------------------------------------- DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Prospective Grant of Exclusive License: Uteroglobin in Treatment of IgA Mediated Autoimmune Disorders Correction In notice document 00-4009 beginning on page 8384 in the issue of Friday, February 18, 2000, make the following corrections: On page 8384, in the third column, seven lines from the bottom, the sentence should end, ``on or before May 18, 2000, will be considered.'' [FR Doc. C0-4009 Filed 3-6-00; 8:45 am] BILLING CODE 1505-01-D
Document
Prospective Grant of Exclusive License: Uteroglobin in Treatment of IgA Mediated Autoimmune Disorders
[Federal Register Volume 65, Number 46 (Wednesday, March 8, 2000)] [Corrections] [Page 12318] From the Federal Register Online via the Government Publishing Office [ www.gpo.gov...
Legal Citation
Federal Register Citation
Use this for formal legal and research references to the published document.
65 FR 12056
Web Citation
Suggested Web Citation
Use this when citing the archival web version of the document.
“Prospective Grant of Exclusive License: Uteroglobin in Treatment of IgA Mediated Autoimmune Disorders,” thefederalregister.org (March 8, 2000), https://thefederalregister.org/documents/C0-4009/prospective-grant-of-exclusive-license-uteroglobin-in-treatment-of-iga-mediated-autoimmune-disorders.